XML 59 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information
3 Months Ended
Mar. 31, 2014
Segment Information [Abstract]  
Segment Information

16.  Segment Information  

 

The Company has two reportable segments organized according to its products and services: Medical Devices and Preservation Services.  The Medical Devices segment includes external revenues from product sales of BioGlue® Surgical Adhesive (“BioGlue”), BioFoam® Surgical Matrix (“BioFoam”), PerClot, revascularization technologies, and HeRO Graft.  The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues.  There are no intersegment revenues. 

 

The primary measure of segment performance, as viewed by the Company’s management, is segment gross margin, or net external revenues less cost of products and preservation services.  The Company does not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below. 

The following table summarizes revenues, cost of products and preservation services, and gross margins for the Company’s operating segments (in thousands): 

 

 

 

 

 

 

 

 

Three Months Ended

 

March 31,

 

2014

 

2013

Revenues:

 

 

 

 

 

Medical devices

$

19,455 

 

$

19,796 

Preservation services

 

16,276 

 

 

15,677 

Othera

 

--

 

 

63 

Total revenues

 

35,731 

 

 

35,536 

 

 

 

 

 

 

Cost of products and preservation services:

 

 

 

 

 

Medical devices

 

3,801 

 

 

3,465 

Preservation services

 

9,457 

 

 

8,795 

Total cost of products and preservation services

 

13,258 

 

 

12,260 

 

 

 

 

 

 

Gross margin:

 

 

 

 

 

Medical devices

 

15,654 

 

 

16,331 

Preservation services

 

6,819 

 

 

6,882 

Othera

 

--

 

 

63 

Total gross margin

$

22,473 

 

$

23,276 

 

 The following table summarizes net revenues by product and preservation services (in thousands): 

 

 

 

 

 

 

 

 

Three Months Ended

 

March 31,

 

2014

 

2013

Products:

 

 

 

 

 

BioGlue and BioFoam

$

15,240 

 

$

15,464 

PerClot

 

916 

 

 

864 

Revascularization technologies

 

1,684 

 

 

2,191 

HeRO Graft

 

1,615 

 

 

1,277 

Total products

 

19,455 

 

 

19,796 

 

 

 

 

 

 

Preservation services:

 

 

 

 

 

Cardiac tissue

 

7,190 

 

 

6,645 

Vascular tissue

 

9,086 

 

 

9,032 

Total preservation services

 

16,276 

 

 

15,677 

 

 

 

 

 

 

Othera

 

--

 

 

63 

Total revenues

$

35,731 

 

$

35,536 

___________________  

aThe “Other” designation includes grant revenue.